• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞纤连蛋白在正常肝脏、肝硬化和肝细胞癌中的免疫定位

Immunolocalization of cellular fibronectins in the normal liver, cirrhosis, and hepatocellular carcinoma.

作者信息

Koukoulis G K, Shen J, Virtanen I, Gould V E

机构信息

Department of Pathology, Rush Medical College, Chicago, IL 60612, USA.

出版信息

Ultrastruct Pathol. 1995 Jan-Feb;19(1):37-43. doi: 10.3109/01913129509014601.

DOI:10.3109/01913129509014601
PMID:7770960
Abstract

Cellular (c) fibronectins (Fn) differ biochemically, immunologically, and functionally from plasma fibronectins (pFn). Most existing data on Fn distribution in the normal and diseased liver require revision because those studies were based on reagents that did not distinguish pFn from cFn and predated the development of specific cFn monoclonal antibodies (Mabs). We immunostained cryosections of normal adult livers (n = 5), cirrhotic livers (n = 20), and livers with hepatocellular carcinoma (HCC) (n = 10) by the avidin-biotin-complex method with specific Mabs to the extradomains A and B (EDA, EDB) and oncofetal (Onc) isoforms of cFn. Selected samples were stained with an antiserum to pFn; fetal livers served as controls. Normal and cirrhotic livers showed EDA-cFn staining in the portal, septal, and perisinusoidal matrix; its distribution was more restricted than that of pFn. In cirrhosis, EDA-cFn reactions were strongest at sites of piecemeal necrosis and around proliferating ductules in biliary cirrhosis. EDA-cFn reactions were consistently most intense in the matrix of HCC. Distinct from adult normal and cirrhotic livers, reactions for EDB- and Onc-cFn were noted exclusively in most cases of HCC. We conclude that the only cFn isoform indigenous to the normal adult liver matrix is EDA-cFn. Enhanced EDA-cFn in cirrhotic livers may serve as indicator of active stromal remodeling. The restriction of EDB- and Onc-cFn to a large subset of HCC and the putative role of cFn in modulating cell-matrix adhesive interactions would suggest that the emergence of these molecules may be related to the variably invasive and metastatic properties of these tumors.

摘要

细胞型(c)纤连蛋白(Fn)在生化、免疫和功能方面与血浆纤连蛋白(pFn)不同。大多数现有的关于Fn在正常和患病肝脏中分布的数据需要修订,因为那些研究是基于无法区分pFn和cFn的试剂,并且早于特异性cFn单克隆抗体(Mab)的开发。我们使用针对cFn的A和B额外结构域(EDA、EDB)以及癌胚(Onc)亚型的特异性Mab,通过抗生物素蛋白-生物素复合物方法对正常成人肝脏(n = 5)、肝硬化肝脏(n = 20)和肝细胞癌(HCC)肝脏(n = 10)的冰冻切片进行免疫染色。选择的样本用抗pFn抗血清染色;胎儿肝脏作为对照。正常和肝硬化肝脏在门静脉、间隔和窦周基质中显示EDA-cFn染色;其分布比pFn更局限。在肝硬化中,EDA-cFn反应在碎片状坏死部位和胆汁性肝硬化中增生的胆小管周围最强。EDA-cFn反应在HCC基质中始终最为强烈。与成人正常和肝硬化肝脏不同,EDB-和Onc-cFn反应仅在大多数HCC病例中观察到。我们得出结论,正常成人肝脏基质中唯一的cFn亚型是EDA-cFn。肝硬化肝脏中EDA-cFn的增强可能作为活跃基质重塑的指标。EDB-和Onc-cFn在大部分HCC中的局限性以及cFn在调节细胞-基质黏附相互作用中的假定作用表明,这些分子的出现可能与这些肿瘤的不同侵袭性和转移性有关。

相似文献

1
Immunolocalization of cellular fibronectins in the normal liver, cirrhosis, and hepatocellular carcinoma.细胞纤连蛋白在正常肝脏、肝硬化和肝细胞癌中的免疫定位
Ultrastruct Pathol. 1995 Jan-Feb;19(1):37-43. doi: 10.3109/01913129509014601.
2
Differential distribution of tenascin and cellular fibronectins in acute and chronic renal allograft rejection.肌腱蛋白和细胞纤连蛋白在急性和慢性同种异体肾移植排斥反应中的差异分布。
Lab Invest. 1992 Jul;67(1):71-9.
3
Immunolocalization of tenascin and cellular fibronectins in diverse glomerulopathies.腱生蛋白和细胞纤连蛋白在多种肾小球疾病中的免疫定位
Virchows Arch B Cell Pathol Incl Mol Pathol. 1993;63(5):307-16. doi: 10.1007/BF02899277.
4
RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma.RT-PCR检测纤连蛋白EDA+和EDB+ mRNA亚型:肝细胞癌的分子标志物
Int J Cancer. 1994 Mar 15;56(6):820-5. doi: 10.1002/ijc.2910560611.
5
Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.腱生蛋白、细胞纤连蛋白和整合素在正常、增生和肿瘤性乳腺中的分布
J Submicrosc Cytol Pathol. 1993 Apr;25(2):285-95.
6
Isoforms of cellular fibronectin and tenascin in amniotic fluid.羊水细胞纤连蛋白和腱生蛋白的亚型
FEBS Lett. 1994 Jan 10;337(2):167-70. doi: 10.1016/0014-5793(94)80266-1.
7
MDR1 gene expression in hepatocellular carcinoma and the peritumoral liver of patients with and without cirrhosis.
Cancer Lett. 2002 Dec 1;186(1):107-13. doi: 10.1016/s0304-3835(02)00155-6.
8
HGF, MET, and matrix-related proteases in hepatocellular carcinoma, fibrolamellar variant, cirrhotic and normal liver.肝细胞癌、纤维板层样变体、肝硬化和正常肝脏中的肝细胞生长因子、间质-上皮转化因子及基质相关蛋白酶
Mod Pathol. 2003 Jan;16(1):14-21. doi: 10.1097/01.MP.0000043521.96995.DB.
9
[Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].[硫酸乙酰肝素蛋白聚糖在肝细胞癌微血管中的选择性沉积:发病机制及鉴别诊断方面]
Magy Onkol. 2008 Dec;52(4):379-83. doi: 10.1556/MOnkol.52.2008.4.7.
10
Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.细胞角蛋白19阳性胆管细胞在肝硬化结节、肝脏交界性结节(非典型腺瘤样增生)及小肝细胞癌中的分布。
Mod Pathol. 1995 May;8(4):371-9.

引用本文的文献

1
An essential role for fibronectin extra type III domain A in pulmonary fibrosis.纤连蛋白额外III型结构域A在肺纤维化中的重要作用。
Am J Respir Crit Care Med. 2008 Mar 15;177(6):638-45. doi: 10.1164/rccm.200708-1291OC. Epub 2007 Dec 20.
2
Growth inhibitory actions of prothrombin on normal hepatocytes: influence of matrix.凝血酶原对正常肝细胞的生长抑制作用:基质的影响。
Cell Biol Int. 2007 Sep;31(9):929-38. doi: 10.1016/j.cellbi.2007.03.001. Epub 2007 Mar 19.
3
Keratocyte phenotype mediates proteoglycan structure: a role for fibroblasts in corneal fibrosis.
角膜细胞表型介导蛋白聚糖结构:成纤维细胞在角膜纤维化中的作用
J Biol Chem. 2003 Nov 14;278(46):45629-37. doi: 10.1074/jbc.M303292200. Epub 2003 Aug 20.
4
Effect of endotoxin on fibronectin synthesis of rat primary cultured hepatocytes.内毒素对大鼠原代培养肝细胞纤连蛋白合成的影响。
World J Gastroenterol. 1998 Aug;4(4):329-331. doi: 10.3748/wjg.v4.i4.329.
5
Cellular fibronectin concentration in the plasma of patients with malignant and benign diseases: a comparison with CA 19-9 and CEA.恶性和良性疾病患者血浆中细胞纤连蛋白浓度:与CA 19-9和癌胚抗原的比较
Br J Cancer. 1997;76(6):777-83. doi: 10.1038/bjc.1997.461.